Search results
Janssen Pharms., Inc. v. Tolmar, Inc. - Invega Sustenna® (Paliperidone Extended-Release Suspension)...
JD Supra· 4 hours agoNature of the Case and Issue(s) Presented: Janssen developed its injectable schizophrenia treatment drug product in response to problems associated with oral administration of antipsychotic ...
Lantheus Holdings Inc (LNTH) Surpasses Q1 2024 Revenue and Earni
Guru Focus· 7 days agoLantheus Holdings Inc (LNTH, Financial) reported a strong financial performance for the first quarter of 2024, with significant increases in revenue and earnings that exceeded ...
Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoBausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript May 2, 2024 Bausch Health...
Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoExelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript April 30, 2024 Exelixis, Inc. misses...
Q1 2024 Amneal Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoParticipants Tony Dimeo; Head of IR; Amneal Pharmaceuticals Inc Chirag Patel; President, Co-CEO, Co-Founder, & Director; Amneal Pharmaceuticals Inc Chintu ...
Bausch (BHC) Q1 Earnings and Revenues Miss, Shares Fall
Zacks via Yahoo Finance· 5 days agoZacks Rank and... #3 (Hold). Some better-ranked stocks in the biotech sector are ANI...
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
Digital Journal· 5 hours agoReports Net Revenues of $171.8 Million for the Three Months Ended March 31, 2024 RANCHO CUCAMONGA, CA / ACCESSWIRE / May 8, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ: ...
How sham patents are hurting the pharma industry
Pharmaceutical Technology via Yahoo Finance· 2 days agoLegal challenges to sham patents often involve litigation, with generic manufacturers filing lawsuits to challenge the validity of questionable patents....
Genentech, Inc. v. Sandoz, Inc. - Esbriet® (Pirfenidone) | JD Supra
JD Supra· 6 days agoNature of the Case and Issue(s) Presented: Plaintiff Hoffman-La Roche (“HLR”) owns the patents-in-suit and Plaintiff Genentech exclusively licenses it. The patent claims a novel tablet formulation ...
NANO Nuclear Energy (NNE) Plans to Raise $15 Million in May 7th IPO
ETF DAILY NEWS· 6 days agoNANO Nuclear Energy (NNE) expects to raise $15 million in an initial public offering on Tuesday, May...
